Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Phizer just bought arena PHarm---

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Dec 13, 2021 3:10pm

550 Views

Post# 34226242

RE:RE:RE:Phizer just bought arena PHarm---

I like your idea better Pop. ;-)

99942Apophis wrote: Rumpl3StiltSkin wrote
I think the buyout, IF we get one, will be by next qtr, $1B Canadian, from Li Ka Shing. Or, more likely in the $3B-7B US, due to a bidding war, after TLT gains BTD and more solid CR% late 2022-early2023. Just IMO.

Theralase's future potential earning from all its cancer indications in my opinion far surpasses 10B then consider your PE Ratio you are looking at a share price worth hundreds of dollars at least!